News Conference News ESC 2024 New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document Caitlin E. Cox September 10, 2024
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
News Daily News FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI L.A. McKeown September 12, 2023
News Daily News PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI L.A. McKeown March 29, 2023
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Conference News ACC 2021 SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal L.A. McKeown May 16, 2021
News Daily News Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail L.A. McKeown April 22, 2021
News Daily News FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited L.A. McKeown January 12, 2021
News Conference News VEITH 2015 DCBs for Femoropoliteal Disease: What’s Now and What’s Next? Yael L. Maxwell November 19, 2015
News Daily News LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea Yael L. Maxwell June 26, 2015
News Daily News LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease Yael L. Maxwell June 26, 2015
News Daily News Experts Give Their Picks for Most Important Developments of 2011 Jason Kahn March 08, 2012